Shopping Cart 0
Cart Subtotal
USD 0

Peanut Allergy: Epidemiology Forecast to 2027

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3995

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 7990

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 11985
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Peanut Allergy: Epidemiology Forecast to 2027

Summary

Peanut allergy is a type of food allergy in which the individual is allergic to peanut, which is part of the legume family. Peanut allergy is an immunoglobulin E (IgE) mediated type-I hypersensitivity reaction in which, once exposed to peanut, the body elicits an inappropriate immune response, causing the symptomology seen in allergic persons. The minimum dose of exposure to elicit an allergic response is highly variable, with some people only requiring trace amounts for a severe reaction.

GlobalData epidemiologists provide a 10-year epidemiological forecast for the probable diagnosed prevalent cases of peanut allergy by age and sex, as well as the probable diagnosed prevalent cases of peanut allergy with associated comorbidity, and the probable diagnosed prevalent cases of peanut allergy by severity.

In the 8MM, GlobalData epidemiologists forecast the probable diagnosed prevalent cases of peanut allergy to increase from 6,899,534 cases in 2017 to 7,271,769 cases in 2027, at an Annual Growth Rate (AGR) of 0.54%. The US will have the highest number of probable diagnosed prevalent cases of peanut allergy throughout the forecast period.

Scope

- The peanut allergy Epidemiology Forecast Report provides an overview of the risk factors and global trends of peanut allergy in the seven major markets (8MM: US, France, Germany, Italy, Spain, UK, Australia, and Canada).

- This report also includes a 10-year epidemiological forecast for the following segmentations in all ages across the 8MM: probable diagnosed prevalent cases of peanut allergy; probable diagnosed prevalent cases of peanut allergy with associated comorbidity, including asthma, atopic dermatitis, tree nut allergy, and other food allergy; and the probable diagnosed prevalent cases of peanut allergy by severity.

- The peanut allergy epidemiology forecast report is written and developed by Masters- and PhD-level epidemiologists.

- The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The Peanut Allergy Epidemiology Forecast report will allow you to-

- Develop business strategies by understanding the trends shaping and driving the global peanut allergy market.

- Quantify patient populations in the global peanut allergy market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for peanut allergy therapeutics in each of the markets covered.

- Understand magnitude of peanut allergy population by mutations.

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Peanut Allergy: Executive Summary 4

2.1 Related Reports 5

3 Epidemiology 6

3.1 Disease Background 6

3.2 Risk Factors and Comorbidities 6

3.3 Global and Historical Trends 7

3.4 Forecast Methodology 8

3.4.1 Sources 9

3.4.2 Forecast Assumptions and Methods 11

3.5 Epidemiological Forecast for Peanut Allergy (2017-2027) 15

3.5.1 Probable Diagnosed Prevalent Cases of Peanut Allergy 15

3.5.2 Age-Specific Probable Diagnosed Prevalent Cases of Peanut Allergy 16

3.5.3 Sex-Specific Diagnosed Prevalent Cases of Peanut Allergy 17

3.5.4 Probable Diagnosed Prevalent Cases of Peanut Allergy with Comorbid Condition 18

3.6 Discussion 19

3.6.1 Epidemiological Forecast Insight 19

3.6.2 Limitations of

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Peanut Allergy: Epidemiology Forecast to 2027

Summary

Peanut allergy is a type of food allergy in which the individual is allergic to peanut, which is part of the legume family. Peanut allergy is an immunoglobulin E (IgE) mediated type-I hypersensitivity reaction in which, once exposed to peanut, the body elicits an inappropriate immune response, causing the symptomology seen in allergic persons. The minimum dose of exposure to elicit an allergic response is highly variable, with some people only requiring trace amounts for a severe reaction.

GlobalData epidemiologists provide a 10-year epidemiological forecast for the probable diagnosed prevalent cases of peanut allergy by age and sex, as well as the probable diagnosed prevalent cases of peanut allergy with associated comorbidity, and the probable diagnosed prevalent cases of peanut allergy by severity.

In the 8MM, GlobalData epidemiologists forecast the probable diagnosed prevalent cases of peanut allergy to increase from 6,899,534 cases in 2017 to 7,271,769 cases in 2027, at an Annual Growth Rate (AGR) of 0.54%. The US will have the highest number of probable diagnosed prevalent cases of peanut allergy throughout the forecast period.

Scope

- The peanut allergy Epidemiology Forecast Report provides an overview of the risk factors and global trends of peanut allergy in the seven major markets (8MM: US, France, Germany, Italy, Spain, UK, Australia, and Canada).

- This report also includes a 10-year epidemiological forecast for the following segmentations in all ages across the 8MM: probable diagnosed prevalent cases of peanut allergy; probable diagnosed prevalent cases of peanut allergy with associated comorbidity, including asthma, atopic dermatitis, tree nut allergy, and other food allergy; and the probable diagnosed prevalent cases of peanut allergy by severity.

- The peanut allergy epidemiology forecast report is written and developed by Masters- and PhD-level epidemiologists.

- The Epidemiology Forecast Report is in-depth, high quality, transparent, and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The Peanut Allergy Epidemiology Forecast report will allow you to-

- Develop business strategies by understanding the trends shaping and driving the global peanut allergy market.

- Quantify patient populations in the global peanut allergy market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for peanut allergy therapeutics in each of the markets covered.

- Understand magnitude of peanut allergy population by mutations.

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Peanut Allergy: Executive Summary 4

2.1 Related Reports 5

3 Epidemiology 6

3.1 Disease Background 6

3.2 Risk Factors and Comorbidities 6

3.3 Global and Historical Trends 7

3.4 Forecast Methodology 8

3.4.1 Sources 9

3.4.2 Forecast Assumptions and Methods 11

3.5 Epidemiological Forecast for Peanut Allergy (2017-2027) 15

3.5.1 Probable Diagnosed Prevalent Cases of Peanut Allergy 15

3.5.2 Age-Specific Probable Diagnosed Prevalent Cases of Peanut Allergy 16

3.5.3 Sex-Specific Diagnosed Prevalent Cases of Peanut Allergy 17

3.5.4 Probable Diagnosed Prevalent Cases of Peanut Allergy with Comorbid Condition 18

3.6 Discussion 19

3.6.1 Epidemiological Forecast Insight 19

3.6.2 Limitations of

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com